8-K12B filed December 20, 2023, 6:59 PM ET ticker SILO CIK 0001514183

other material confidence high sentiment neutral materiality 0.35

Silo Pharma reincorporates from Delaware to Nevada, effective December 19, 2023

Silo Pharma, Inc.

Reincorporation completed via Plan of Conversion approved by stockholders on Dec 4/11, 2023.
Each outstanding share of Delaware common stock converted one-for-one into Nevada common stock.
Options, warrants, and equity plans continue on same terms; no exchange of stock certificates required.
Ticker remains SILO on Nasdaq; business, management, and offices unchanged.
Stockholder rights now governed by Nevada law; differences detailed in Oct 23, 2023 proxy statement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.